Designed to promote the discovery of new-generation medicine
28 000 compounds
RNA-focused drug discovery has dramatically changed over the last decade and has become the most exciting frontier in developing new-generation pharmaceuticals for better healthcare. This new stage of RNA investigation, also called “RNAissance” owes to recent advances in genetic engineering and genome sequencing. This gives us high anticipation for discovering efficient medications against difficult-to-treat and incurable diseases, along with new antibacterials and antivirals.
RNA is a versatile biomolecule capable of transferring information, adopting distinct three-dimensional shapes, and responding to ambient conditions. These biological structures can carry out a wide range of functions, from translating genetic information into the molecular machines and structures of the cell to regulating the activity of genes during development, cellular differentiation, changing environments, and more.
We focused on investigating three main types of interactions of small molecules with RNA secondary structures and 3D fold of tRNAs, and mRNAs (avoiding direct targeting of RNA helix and intercalation) with virtual screening of available structures of G-quadruplex and Riboswitches.
The library has been plated for the most convenient and quick access. Using our RNA library you receive multiple benefits, allowing you to save on time and costs in hit exploration and optimization:
- Hit confirmation support: Analogs search and hit samples resupply from dry stock with strict QC
- Straightforward & affordable synthesis of hit follow-up libraries by parallel chemistry
- Medicinal chemistry support enhanced with on-site broad ADME/T panel
Typical Formats
RNA Library is available for supply in various pre-plated formats, including the following most popular ones:
Catalog No.
RNA-28-5-Y-10
Compounds
28 000
88 plates
Amount
5 µL of 10 mM DMSO solutions
Plates and formats
384-well acoustic LDV microplates, 320 compounds per plate, 1, 2 & 23, 24 columns empty
Price
Catalog No.
RNAS-10400-10-Y-10
Compounds
10 400
33 plates
Amount
10 µL of 10mM DMSO solutions
Plates and formats
384-well, echo qualified LDV microplates #001-12782 (LP-0200), first and last two columns empty, 320 compounds per plate
Price
Catalog No.
RNAR-14800-20-Y-10
Compounds
14 800
47 plates
Amount
20 µL of 10 mM DMSO solutions
Plates and formats
384-well plates Greiner #781280, 320 compounds per plate, first two and last two columns empty
Price
Catalog No.
RNAG4-2800-50-X-10
Compounds
2 800
35 plates
Amount
50 µL of 10mM DMSO solutions
Plates and formats
96-well plates, Greiner #650160, 80 compounds per plate, 1 & 12 columns empty
Price
*We will be happy to provide our library in any other most convenient for your project format. Please select among the following our standard microplates: Greiner Bio-One 781270, 784201, 781280, 651201 or Echo Qualified 001-12782 (LP-0200), 001-14555 (PP-0200), 001-6969 (LP-0400), C52621 or send your preferred labware. Compounds pooling can be provided upon request.
Download SD files
Library design
G-quadruplexes are high-order, four-stranded structures formed by repeated guanine tracts in the genome. Despite the significant prevalence of DNA G-quadruplexes over RNA, RNA quadruplexes remain crucial in various biological processes such as epigenetic regulation, telomere maintenance, mitochondrial RNA expression, and many others. We analyzed all reported RNA G-quadruplexes (G4s) structures and created 6 docking models based on RNA aptamers and modeling of h-MYC G4s.
Riboswitches are bacterial regulatory segments of mRNA and consist of a metabolite-binding aptamer and an expression platform. They are essential for different processes: expression of viral genes, gene-regulating function, production control of the proteins encoded by the mRNA, catalyze reactions, bind to other RNA or regulatory macromolecules, and many more. Given their absence in mammalian cells, riboswitches are very attractive targets for the discovery of new antibacterials. Over 20 docking models have been created and used for in silico screening of the following riboswitches: 2-deoxyguanosine, c-di-AMP, c-di-GMP, class I PreQ1, FMN, glmS ribozyme with G40A mutation, Glutamine II, Glycine, Guanine, L-glutamine, Lysine, metY SAM V, preQ1 Class II, PreQ1, PRPP, s-adenosylhomocysteine, SMK box (SAM-III), THF, thi-Box, thi-M, ZTP riboswitch.
RNA splicing regulation is probably the most attractive in eukaryotic drug discovery. Modulation of RNA splicing would be one of the most effective ways for cancer treatment and genetic disorders. We focused on the targeting of regulatory and precursor mRNAs and kinases, which activity required for RNA splicing: serine and arginine-rich splicing factor protein kinases SRPKs and CDC2-like kinases CLKs.
The structure-based approach (molecular docking) has been used as a main technique for library construction. All available PDB structures of RNA G4s, riboswitches, mRNAs and SRPK and CLK kinase swere analyzed. Unique "protein-ligand" complexes were selected for further analysis and docking model constructions. The following PDB structures were used for G4s: 6C63, 6e81, 6E81, 6E8S, 7oa3, 8EYV; and Riboswitches: 2hom, 2miy, 3b4b, 3d0u, 3e5e, 3irw, 3npn, 3p49, 3q50, 3ski, 4lvy, 4nya, 4nyb, 4nyd, 4qk8, 4rzd, 5c45, 5ddq, 6ck4, 6fz0, 6p2h, 6qn3, 6uc8, 6uc9, 6wzs.
Pharmacophore models are represented below using the following color scheme: red spheres - H-bond acceptors, blue – Hb donors, orange – aromatic groups, and grey spheres represent any other atom types, purple – mixed acceptor/donor groups. RNA nucleobases are highlighted in green, the native is yellow, and an example of a docked ligand is shown in grey.
Examples of molecular docking simulation, and used pharmacophore models, G-quadruplex
Example 1 (PDB ID 5bjp, RNA aptamer)

Example 1. The potential ligand should contain two aromatic features to create stacking interaction with G25, A24, G12, and G22. Additionally, it should be capable of forming hydrogen bond interactions with two HOH (water) molecules.
Example 2 (PDB ID 6c63)

Example 2. The ligand must contain two aromatic parts for stacking interaction with G13, G18, A12, and G29. At another part of the pocket, it should just fill in the sub-pocket formed by A23 and G24.
Examples of molecular docking simulation, and used pharmacophore models, riboswitches
Example 1 (PDB ID 3e5e, SAM Riboswitch)

Example 1. According to the used pharmacophore model ligand should contain an aromatic part to interact by stacking interactions with U37, and G48, Any atom part just to fill in the sub-pocket behind U37, and 3 donors of h-bond interaction (two acceptors, and one donor) to interact with G7, A38. It is important to note here, that the ligand should contain at least 2 of 3 h-bond interaction features used in the pharmacophore model.
Example 2 (PDB ID 3d0u, Lysine Riboswitch)

Example 2. In this case, the ligand should contain a string acceptor to imitate the COOH lysine group, and on the other part of the pocket NH3 group to crate caton-p interaction with surrounding nucleotides.
Diverse covalent library with most demanded warhead types
11 760 compounds
Covalent probes play an essential role in the discovery of new technologies, investigation of new proteins, and assessment of their drugability. We at Enamine have been working since 2016 on synthesis on covalent compounds and development of new covalent warheads.
Enamine focused on the elaboration of parallel synthesis approaches to synthesize a series of new valuable covalent compounds with well-working and not overreactive warheads. All our efforts resulted in the production of the largest commercially available Collection of Covalent Compounds. Most interesting and popular covalent classes were assembled into a diverse Library, aimed to represent Enamine’s Covalent Collection.
The Library is available in pre-plated format at 10 mM concentration in DMSO. Each covalent binder type is plated in separate plates.
Typical Formats
Covalent Screening Library is available for supply in various pre-plated formats, including the following most popular ones:
Catalog No.
Covalent Screening Library
CSL-11-10-Y-10
Compounds
11 760
37 plates
Amount
10 µL of 10 mM DMSO solutions
Plates and formats
384-well, Echo Qualified LDV microplates #001-12782 (LP-0200), first and last two columns empty, 320 compounds per plate
Price
Catalog No.
Representative Set
CSRS-320-20-Y-10
Compounds
320
1 plate
Amount
20 μL of 10 mM DMSO solutions
Plates and formats
384-well Echo Qualified LDV plates, 1, 2 and 23, 24 columns empty, 320 compounds per plate
Price
Catalog No.
Acrylamides
CSAC-4160-20-Y-10
Compounds
4 160
13 plates
Amount
20 μL of 10 mM DMSO solutions
Plates and formats
384-well plates, Greiner #765021, 1, 2 and 23, 24 columns empty, 320 compounds per plate
Price
Catalog No.
Cyanacrylamides
CSCN-1920-10-Y-10
Compounds
1 920
6 plates
Amount
10 µL of 10 mM DMSO solutions
Plates and formats
384-well echo LDV plates, #LP-200, 1,2 and 23,24 columns empty, 320 compounds per plate
Price
Catalog No.
Chloroacetamides
CSCL-1200-25-Y-10
Compounds
1 200
4 plates
Amount
25 μL of 10 mM DMSO solutions
Plates and formats
384-well plates, Greiner #784201, 1, 2 and 23, 24 columns empty, 320 compounds per plate
Price
Catalog No.
Vinyl Sulfones
CSVS-640-50-X-10
Compounds
640
2 plates
Amount
50 µL of 10 mM DMSO solutions
Plates and formats
96-well plates, 2D-barcoded Matrix microtubes #4271, 1 and 12 columns empty, 80 compounds per plate
Price
Catalog No.
Formyl Boronates
FBA-480-15-Y-10
Compounds
480
2 plates
Amount
15 µL of 10 mM DMSO solutions
Plates and formats
384-well echo plates, Labcyte #PP-0200, 1,2 and 23,24 columns empty, 320 compounds per plate
Price
*We will be happy to provide our library in any other most convenient for your project format. Please select among the following our standard microplates: Greiner Bio-One 781270, 784201, 781280, 651201 or Echo Qualified 001-12782 (LP-0200), 001-14555 (PP-0200), 001-6969 (LP-0400), C52621 or send your preferred labware. Compounds pooling can be provided upon request.
Download SD files
Key features
- Careful choice of warheads: only experimentally confirmed, well-validated, and reported in the number of papers. No overreactive binders.
- All compounds in the library feature a certain chemotype, “recognition pattern”, to avoid promiscuous bindings.
- Compounds plated by classes for ease of reactivity analysis and residue-focusing screening campaigns.
Examples of molecules in the library

Distribution by covalent warheads

Selected molecules able to mimic common protein motifs
8 960 compounds
Over 250 000 individual protein-protein interactions (PPIs) were identified in human proteome. Although many of these exhibit topologically complex and formidable surface areas, in many instances the successful binding is attained via a limited number of key residues ("hot spots“). There are multiple reports in the literature describing both computational and diversity-oriented approaches to developing small-molecule modulators of PPIs. Of these, non-peptidic a-helix and b-turn imetics are of particular importance due to their key role in multiple deregulated pathways leading to cancer, neurodegenerative disorders, inflammation and immunological disorders.
Typical Formats
Protein Mimetics Library is available for supply in various pre-plated formats, including the following most popular ones:
Catalog No.
PML-8-0-Z-10
Compounds
8 960
7 plates
Amount
≤ 300 nL of 10 mM of DMSO solutions
Plates and formats
1536-well Echo LDV microplates, first and last four columns empty, 1280 compounds per plate
Price
Catalog No.
PML-8-10-Y-10
Compounds
8 960
28 plates
Amount
10 µL of 10 mM DMSO solutions
Plates and formats
384-well, Echo Qualified LDV microplates #001-12782 (LP-0200), first and last two columns empty, 320 compounds per plate
Price
Catalog No.
PML-8-50-Y-10
Compounds
8 960
28 plates
Amount
50 μL of 10 mM DMSO solutions
Plates and formats
384-well, Greiner Bio-One plates #781280, first and last two columns empty, 320 compounds per plate
Price
Catalog No.
Library & follow-up package
Plates and formats
PML-8-10-Y-10 screening library 8 960 cmpds, hit resupply, analogs from 4.4M+ stock and synthesis from REAL Space
Price
*We will be happy to provide our library in any other most convenient for your project format. Please select among the following our standard microplates: Greiner Bio-One 781270, 784201, 781280, 651201 or Echo Qualified 001-12782 (LP-0200), 001-14555 (PP-0200), 001-6969 (LP-0400), C52621 or send your preferred labware. Compounds pooling can be provided upon request.
Download SD files
Library code: PML-8960
Version: 29 September 2023
8 960 compounds
sublibrary of PPI-40
Library design
Traditional three residue approach

Alpha-helix Mimetics






Beta-turn Mimetics

Ligand-based approach
Target based approach. We carried out design of a focused compound set targeting selected alpha-helix domains and beta-turns such as mdm2-p53, mdm2-CK1α, HIF1-α , MEF2-HDAC4, HIV-1 gp41, CD81/CV, Bcl-2/Bcl-xL, etc. After the selection by virtual screening the preference was set to the structures bearing new chemotypes.
‘Traditional’ three-residue appraoch included design of compounds with unusual cores bearing regular key-residues that mimics i, i+3/i+4 and i+7-residues located on the one recognition face (‘hot spots’). In modeling a-helix interfaces, we accounted also two-face helix mimetics. For beta-turn mimetics we applied three query models with distinct types of interaction: π-π stacking, cation-π and H-bond interaction, S-π interaction. : The latter focused design exercise was exemplified by modeling the interaction between Bim BH3 domain with Mcl-1 and Bcl-2 and identifying fused polyhydrogenated aza-heterocycles with high Fsp3 character.
Ligand based approach. New chemotypes with close topology to known alpha-helix and beta-turns mimetics were selected. Shape based similarity and Pharmacophore screening were used as a main tools for the library design.
Unique Fsp3-enriched scaffolds exhibiting ladder-like cyclic skeletons were specially selected to enhance topological and pharmacophore interaction with the target alpha-helix and beta-turn motifs.
Examples of Selected Scaffolds in the Library




The ultimate selection of Lys-specific binders
1 600 compounds

Until recently, covalent binders targeting Lysine residue attracted less attention as compared to those modifying Cysteine or Serine. Being among the essential amino acids, Lysine can be found both at the surface and in active sites of many enzymes (e.g. kinases, viral polymerases and integrases, aldolases, DOPA decarboxylase, P-glycoprotein), and it can also participate in catalytic reactions. Moreover, Lys residue is often involved as a key player in many important signaling and metabolic processes. An example can be protein ubiquitination, which mainly occurs through lysine residues on substrate proteins or itself. Selective modification of Lys residue becomes more and more attractive for the investigation of many signaling processes in live cells and, potentially, can play a key role in the discovery of next-generation drugs.
Lysine focused Library is plated at 20 mM concentration in DMSO and is available for fast supply in any custom format. Compounds pooling based on delta MW can be provided as a formatting option. Please request the list of expected molecular weight shifts for MS-based screenings.
Typical Formats
Lysine-Focused Covalent Library is available for supply in various pre-plated formats, including the following most popular ones:
Catalog No.
LYS-1600-0-Z-10
Compounds
1 600
2 plates
Amount
≤ 300 nL of 10 mM of DMSO solutions
Plates and formats
1536-well Echo LDV microplates, first and last four columns empty, 1280 compounds per plate
Price
Catalog No.
LYS-1600-10-Y-10
Compounds
1 600
5 plates
Amount
10 µL of 10 mM DMSO solutions
Plates and formats
384-well, Echo Qualified LDV microplates #001-12782 (LP-0200), first and last two columns empty, 320 compounds per plate
Price
Catalog No.
LYS-1600-50-Y-10
Compounds
1 600
5 plates
Amount
50 μL of 10 mM DMSO solutions
Plates and formats
384-well, Greiner Bio-One plates #781280, first and last two columns empty, 320 compounds per plate
Price
Catalog No.
Library & follow-up package
Plates and formats
LYS-1600-10-Y-10 screening library 1 600 cmpds, hit resupply, analogs from 4.4M+ stock and synthesis from REAL Space
Price
*We will be happy to provide our library in any other most convenient for your project format. Please select among the following our standard microplates: Greiner Bio-One 781270, 784201, 781280, 651201 or Echo Qualified 001-12782 (LP-0200), 001-14555 (PP-0200), 001-6969 (LP-0400), C52621 or send your preferred labware. Compounds pooling can be provided upon request.
Download SD file
Examples of compounds in the library
To address the increased interest and need for lysine-specific covalent binders, we have synthesized several libraries bearing warheads described as selective/preferred toward Lysine. Our renewed library contains only specially synthesized compounds with Lys-specific covalent warheads. The following types of covalent binders were used for the library construction:
Salicylic aldehydes
- Lys-specific, reversible
- The o-hydroxy group stabilizes covalent adducts
- Low reactivity

Vinyl Sulfonamides
- Irreversible binders
- Showed some selectivity toward Lys over Cys
- Highly reactive

α-Formyl Boronic acids
- Reversible and Lys specific
- Boronic residue in α-position dramatically enhances the stability of resulting adducts

Sulfonyl Fluorides
- Irreversible binders for Lys, pH-dependent
- Reactivity depends on structure
- Compounds selected to display moderate reactivity

Distribution by covalent warhead

The library can be screened directly at Enamine in our biology laboratories, which offer a wide range of screening techniques including MS-based screening, kinetics, and intrinsic reactivity measurements. In this case, we will be happy to offer you a discount on library costs and follow-up services depending on the collaboration scope.
Ultimate tool for fragment screening
7 500 compounds
Solubility is critically important for fragment-based screening; assured solubility of fragments at high concentrations can prevent a number of issues during the screening procedure. We have confirmed experimentally aqueous solubility for 7 500 fragments in standard phosphate buffer at 1 mM; measurements were performed using nephelometry-based method. Representative subset of 3 000 compounds was designed using multi-vectoral diversity selection.
Key features:
- High structural diversity was achieved via two approaches: diversity selection using fingerprint-based Tanimoto distance and molecular framework frequency analysis. Compounds bearing trivial and abundant chemotypes were removed to enhance novelty of the set.
- Guaranteed aqueous solubility at 1 mM in PBS buffer and at 200 mM in DMSO
- Soluble Fragment Diversity Set can be readily followed with analogues either from stock or from validated syntheses. All required building blocks are available from Enamine stock.